304 related articles for article (PubMed ID: 19067864)
1. New emollient with topical corticosteroid-sparing effect in treatment of childhood atopic dermatitis: SCORAD and quality of life improvement.
Msika P; De Belilovsky C; Piccardi N; Chebassier N; Baudouin C; Chadoutaud B
Pediatr Dermatol; 2008; 25(6):606-12. PubMed ID: 19067864
[TBL] [Abstract][Full Text] [Related]
2. An innovative oat-based sterile emollient cream in the maintenance therapy of childhood atopic dermatitis.
Mengeaud V; Phulpin C; Bacquey A; Boralevi F; Schmitt AM; Taieb A
Pediatr Dermatol; 2015; 32(2):208-15. PubMed ID: 25529232
[TBL] [Abstract][Full Text] [Related]
3. Quality of life of parents living with a child suffering from atopic dermatitis before and after a 3-month treatment with an emollient.
Gelmetti C; Boralevi F; Seité S; Grimalt R; Humbert P; Luger T; Stalder JF; Taïeb A; Tennstedt D; Garcia Diaz R; Rougier A
Pediatr Dermatol; 2012; 29(6):714-8. PubMed ID: 23106672
[TBL] [Abstract][Full Text] [Related]
4. The steroid-sparing effect of an emollient therapy in infants with atopic dermatitis: a randomized controlled study.
Grimalt R; Mengeaud V; Cambazard F;
Dermatology; 2007; 214(1):61-7. PubMed ID: 17191050
[TBL] [Abstract][Full Text] [Related]
5. Impact of daily use of emollient 'plus' on corticosteroid consumption in patients with atopic dermatitis: An open, randomized controlled study.
Zelenkova H; Kerob D; Salah S; Demessant-Flavigny AL
J Eur Acad Dermatol Venereol; 2023 Jun; 37 Suppl 5():27-34. PubMed ID: 37092256
[TBL] [Abstract][Full Text] [Related]
6. Novel topical agent containing superoxide dismutase 100 000 IU and 4% of plant extracts as a mono-therapy for atopic dermatitis.
Sgouros D; Katoulis A; Rigopoulos D
J Cosmet Dermatol; 2018 Dec; 17(6):1069-1072. PubMed ID: 29134748
[TBL] [Abstract][Full Text] [Related]
7. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
[TBL] [Abstract][Full Text] [Related]
8. Use of an emollient as a steroid-sparing agent in the treatment of mild to moderate atopic dermatitis in children.
Lucky AW; Leach AD; Laskarzewski P; Wenck H
Pediatr Dermatol; 1997; 14(4):321-4. PubMed ID: 9263319
[TBL] [Abstract][Full Text] [Related]
9. The proactive wet-wrap method with diluted corticosteroids versus emollients in children with atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled trial.
Janmohamed SR; Oranje AP; Devillers AC; Rizopoulos D; van Praag MC; Van Gysel D; Goeteyn M; de Waard-van der Spek FB
J Am Acad Dermatol; 2014 Jun; 70(6):1076-82. PubMed ID: 24698702
[TBL] [Abstract][Full Text] [Related]
10. A randomized double-blind controlled trial to compare a triclosan-containing emollient with vehicle for the treatment of atopic dermatitis.
Tan WP; Suresh S; Tey HL; Chiam LY; Goon AT
Clin Exp Dermatol; 2010 Jun; 35(4):e109-12. PubMed ID: 19843084
[TBL] [Abstract][Full Text] [Related]
11. Does Order of Application of Emollient and Topical Corticosteroids Make a Difference in the Severity of Atopic Eczema in Children?
Ng SY; Begum S; Chong SY
Pediatr Dermatol; 2016; 33(2):160-4. PubMed ID: 26856694
[TBL] [Abstract][Full Text] [Related]
12. The regular use of an emollient improves symptoms of atopic dermatitis in children: a randomized controlled study.
Tiplica GS; Boralevi F; Konno P; Malinauskiene L; Kaszuba A; Laurens C; Saint-Aroman M; Delarue A
J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1180-1187. PubMed ID: 29419920
[TBL] [Abstract][Full Text] [Related]
13. Emollients improve treatment results with topical corticosteroids in childhood atopic dermatitis: a randomized comparative study.
Szczepanowska J; Reich A; Szepietowski JC
Pediatr Allergy Immunol; 2008 Nov; 19(7):614-8. PubMed ID: 18208463
[TBL] [Abstract][Full Text] [Related]
14. Belgian observational drug utilization study of pimecrolimus cream 1% in routine daily practice in atopic dermatitis.
De Backer M; Morren MA; Boonen H; Boyden B; Vertruyen A; Lecomte P; Paquay C; Lesaffre E; Lambert J
Dermatology; 2008; 217(2):156-63. PubMed ID: 18525202
[TBL] [Abstract][Full Text] [Related]
15. Children with Dry Skin and Atopic Predisposition: Outcome Measurement with Validated Scores for Atopic Dermatitis.
Sawatzky S; Schario M; Stroux A; Lünnemann L; Zuberbier T; Blume-Peytavi U; Garcia Bartels N
Skin Pharmacol Physiol; 2016; 29(3):148-56. PubMed ID: 27271265
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study).
Eberlein B; Eicke C; Reinhardt HW; Ring J
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):73-82. PubMed ID: 18181976
[TBL] [Abstract][Full Text] [Related]
17. Natural peroxisome proliferator-activated receptor-alpha agonist cream demonstrates similar therapeutic response to topical steroids in atopic dermatitis.
De Belilovsky C; Roo-Rodriguez E; Baudouin C; Menu F; Chadoutaud B; Msika P
J Dermatolog Treat; 2011 Dec; 22(6):359-65. PubMed ID: 20964572
[TBL] [Abstract][Full Text] [Related]
18. Long-term emollient therapy improves xerosis in children with atopic dermatitis.
Boralevi F; Saint Aroman M; Delarue A; Raudsepp H; Kaszuba A; Bylaite M; Tiplica GS
J Eur Acad Dermatol Venereol; 2014 Nov; 28(11):1456-62. PubMed ID: 24267728
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic efficacy and safety of loratadine syrup in childhood atopic dermatitis treated with mometasone furoate 0.1 per cent cream.
Chunharas A; Wisuthsarewong W; Wananukul S; Viravan S
J Med Assoc Thai; 2002 Apr; 85(4):482-7. PubMed ID: 12118496
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerance assessment of a new type of dermocosmetic in infants and children with moderate atopic dermatitis.
Gayraud F; Sayag M; Jourdan E
J Cosmet Dermatol; 2015 Jun; 14(2):107-12. PubMed ID: 25807867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
